When the DSG2 was first identified in 2011, it was observed that Pt-Dd binding to DSG2 triggered an epithelial-to-mesenchymal transition (EMT) on breast cancer cells (B474), leading to transient opening of intercellular junctions [18]. This evidence concerns the gene DSG2 and breast carcinoma.